J. Blatter

Phase II study of gemcitabine in patients with advanced pancreatic cancer

J Carmichael, U. Fink, RC Russell et al. · British Journal of Cancer · 1996 · 370 citations · Full text

Urology, Pancreatic Cancer, Gastrointestinal Oncology +7

Phase II Study of Pemetrexed With and Without Folic Acid and Vitamin B₁₂ as Front-Line Therapy in Malignant Pleural Mesothelioma

Giorgio V. Scagliotti, Dong-M. Shin, Hedy L. Kindler et al. · Journal of Clinical Oncology · 2003 · 255 citations

Pemetrexed Plus Cisplatin or Pemetrexed Plus Carboplatin for Chemonaïve Patients with Malignant Pleural Mesothelioma: Results of the International Expanded Access Program

Armando Santoro, Mary O’Brien, Rolf A. Stahel et al. · Journal of Thoracic Oncology · 2008 · 247 citations

Chemonaïve Patients, Malignant Pleural Mesothelioma, Medicine +6

Phase III Trial of Pemetrexed Plus Best Supportive Care Compared With Best Supportive Care in Previously Treated Patients With Advanced Malignant Pleural Mesothelioma

Jacek Jassem, Rodryg Ramlau, Armando Santoro et al. · Journal of Clinical Oncology · 2008 · 230 citations · Full text

Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514, Pemetrexed disodium, ALIMTA™ and cisplatin: A multicenter phase II trial

C. Manegold, U. Gatzemeier, Joachim von Pawel et al. · Annals of Oncology · 2000 · 155 citations

Pemetrexed Disodium, Medicine, Metronomic Therapy +10